Tazarotene Cream 0.1% is a prescription medicine used on the skin (topically) to treat people with plaque psoriasis and is also used on the skin to treat people with acne vulgaris. It is not known if Tazarotene Cream is safe and effective for treating psoriasis in children less than 18 years of age, or for treating acne vulgaris in children less than 12 years of age.
Important Safety Information
- Tazarotene Cream and other retinoids may cause fetal harm when administered to a pregnant woman. Do not use Tazarotene Cream if you are pregnant, attempting to become pregnant or at high risk of pregnancy. Consult your physician for adequate birth control measures if you are a female of child-bearing potential. To help assure that you are not pregnant when you begin use, take a pregnancy test within 2 weeks prior to beginning to use Tazarotene Cream and/or begin taking Tazarotene Cream during a normal menstrual period.
- Tazarotene Cream should not be used if you are allergic to any of its ingredients. Please see complete Information for Patients for a list of ingredients.
- Tazarotene Cream should not be used if you are also taking other drugs that increase your sensitivity to sunlight. Inform your physician if you are taking any other medications. Use protective clothing and sunscreens of at least SPF 15 during the day when using Tazarotene Cream. Do not use Tazarotene Cream if you have sunburn, eczema, or other continuing skin conditions. Use Tazarotene Cream with caution if you are using other topical products that might dry or irritate the skin.
- The most common side effects of Tazarotene Cream are peeling, burning/stinging, dry skin, red skin, and itching.
For additional safety and other information, including Patient Information, please see Full Prescribing Information. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.